Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2

Carneiro, Jorge David Aivazoglou; Ramos, Gabriel Frizzo; de Carvalho, Werther Brunow; Johnston, Cíntia; Delgado, Artur Figueiredo.
Clinics ; 75: e2252, 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1142783

Documentos relacionados

  1. Perioperative management of antithrombotics in elective intracranial procedures: systematic review, critical appraisal.
  2. Patient's Perceptions of Importance of Discontinuing Antithrombotic Medication Before Oculoplastics Surgery.
  3. Influence of Steric Shield on Biocompatibility and Antithrombotic Activity of Dendritic Polyphosphate Inhibitor.
  4. Alteplase and Thrombectomy - Not a Bridge to Dismantle.
  5. Fibrinolytic therapy for COVID-19: a review of case series.
  6. Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19?
  7. A national clinician survey on the British Society for Dermatological Surgery guidelines on antithrombotic agent use in skin surgery.
  8. Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score.
  9. Perioperative management of antithrombotic drugs in skin surgery - A survey of dermatologists in Germany.
  10. Intra-operative blood transfusion in elderly patients on antithrombotic therapy.